Abstract
Musculoskeletal pain (MSP) is common and accounts for about a third of all acute and chronic pain syndromes. MSP is a collective term for various diseases. It is a significant burden for patients, society and healthcare. Patients with MSP need for a multimodal therapeutic approach, and correct assessment of clinical status from the perspective of psychophysiological model will be important for determining and influencing the pathogenetic mechanisms of disease. The review is devoted to non-drug treatment of MSP. The authors analyze neuroimaging correlates of analgesia process involving gray matter near cerebral aqueduct and ventral medial prefrontal cortex in patients with MSP. Various pain syndromes and types of nonpharmacological (hardware and psychophysiological) management are considered (therapy with biofeedback based on EMG or cerebral alpha-rhythm, neuromodulation using transcranial magnetic stimulation or transcranial direct current stimulation, virtual and additional reality technologies, stable platforms with biofeedback).

This publication has 44 references indexed in Scilit: